WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'8201 Infant (under 12 months) mortality rate: 332
GDP / capita (US$): 9'9641 Child (under 5 years) mortality rate: 452

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 2'459  2'403  2'347  2'292  2'240  1'898  1'415  1'013 
Births 72  71  70  69  68  59  54  43 
Surviving infants 70  69  68  67  65  56  50  40 
Pop. less than 5 years 338  331  321  311  302  276  234  188 
Pop. less than 15 years 902  887  872  857  845  768  618  472 
Female 15-49 years 654  640  625  610  595  481  338  221 

Number of reported cases

(Click for retrospective incidence data for Namibia)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  212  477  1'028  86  79  469 
Mumps
ChartChart
 
Pertussis
ChartChart
  16  30 
Polio*
ChartChart
 
Rubella
ChartChart
  625  357  40  42  140 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  10 
Tetanus (total)**
ChartChart
  10  148  19 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Namibia)
Vaccine year result method % card seen                                                
BCG 2012  94  DHS   70  94  97  94  90  89  77  88 
DTP1 2012  93  DHS   70  98  92  94  89  88  90 
DTP3 2012  84  DHS   70  92  88  89  84  82  79  59 
DTP4          55 
IPV1         
HepB_BD          87 
HepB3 2012  84  DHS   70  92  88  89  84  82 
Hib3 2012  84  DHS   70  92  88  89  84  82 
JapEnc         
MCV1          85  83  82  76  74  69  57 
MCV2         
PCV1          89  61 
PCV3          81 
Pol3 2012  74  DHS   70  92  88  89  84  85  80  59 
Rota1          91  61 
RotaC          87 
Rubella1         
TT2plus 2012  36  DHS   70  70  71  72  67  64  60  50 
PAB         
VAD1          83  82  75  74 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Namibia)
BCG
ChartChart
  94  97  94  90  89  77 
DTP1
ChartChart
  98  92  94  89  88  90 
DTP3
ChartChart
  92  88  89  84  82  79 
HepB3
ChartChart
  92  88  89  84  82 
HepB_BD
ChartChart
  87 
Hib3
ChartChart
  92  88  89  84  82 
IPV1
ChartChart
 
MCV1
ChartChart
  85  83  82  76  74  69 
MCV2
ChartChart
 
PAB
ChartChart
  85  85  83  83  83  74 
PCV3
ChartChart
  81 
Pol3
ChartChart
  92  88  89  84  85  80 
RCV1
ChartChart
 
RotaC
ChartChart
  87 

Number of districts in the country 34  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 59
From 80 to 89% 38
From 50 to 79% 6
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5,10 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth;
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; 5, 10 years; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +6 weeks; +6 months; +1, +1 year; Yes
VitaminA 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2016 - 2020  2011-2015  2011-2015  2011 - 2015  2011 - 2015  2011 - 2015   
Nº of districts with microplans that include activities to raise immunization coverage number 34         

System performance

Total Nº districts in country number 34  34  35  34  34  34  34 
Nº districts with DTP3 coverage >=80% number 33  25  31  23  23  23  22 
% of districts with DTP3 coverage >=80% From 0 to 100% 97  74  89  68  68  68  65 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 15  15  20  12  15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  Yes  Yes  No    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%         100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.